![]() |
市場調查報告書
商品編碼
1961274
疝氣修補器材市場 - 全球產業規模、佔有率、趨勢、機會、預測:按產品類型、手術類型、手術方式、地區和競爭格局分類,2021-2031年Hernia Repair Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Procedure Type, By Surgery Type, By Region & Competition, 2021-2031F |
||||||
全球疝氣修復器材市場預計將從 2025 年的 64.5 億美元成長到 2031 年的 77.8 億美元,複合年成長率為 3.17%。
這些裝置包括用於疝氣修補手術中重建或加強組織壁的專用外科網片和固定系統。該領域的發展主要受人口老化和肥胖率上升的驅動,這兩者都會增加腹壁缺損的生理易感性。此外,微創腹腔鏡手術和機器人輔助手術的持續發展也加速了對先進生物材料和合成修復材料的需求。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 64.5億美元 |
| 市場規模:2031年 | 77.8億美元 |
| 複合年成長率:2026-2031年 | 3.17% |
| 成長最快的細分市場 | 疝氣修補網裝置 |
| 最大的市場 | 北美洲 |
然而,對術後併發症和與合成網片植入相關的訴訟的持續審查,正為市場擴張帶來阻力。這可能會延遲監管核准,並影響臨床應用。儘管存在這些監管挑戰,但現有醫療體系內的手術數量仍居高不下,確保了對修復器械的穩定需求。例如,英國英國外科醫學院報告稱,疝氣修補術仍將是2024年最常見的外科手術之一,英國每年將進行超過12萬例手術。
機器人和腹腔鏡手術平台的技術進步正在改變市場格局,顯著提升手術精準度並加快患者康復速度。微創技術的這一趨勢在一般外科手術數量的成長中尤為明顯,機器人系統已成為複雜腹壁重組的標準配置。根據直覺外科公司(Intuitive Surgical)截至2025年1月的初步數據,2024年全球達文西手術量預計將成長約17%,這一成長主要得益於美國一般外科手術的應用。這項技術的應用正在推動大量手術的開展,TELA Bio指出,到2025年,美國每年將進行約150萬例疝氣修補手術,繼續保持其作為主要手術項目之一的地位。
同時,隨著外科醫生努力減少與永久性合成植入相關的慢性發炎反應,生物材料和可吸收生物網狀材料的創新正在推動市場發展。這些先進的基質旨在支持自然組織重塑並最大限度地降低復發風險,從而滿足高風險患者群體的關鍵需求。這些混合支架的商業性成功凸顯了材料領域向能夠保留解剖結構的重大轉變。根據 Fierce Biotech 於 2025 年 12 月報道,TELA Bio 宣布其 2024 年全年銷售額為 6,930 萬美元(年成長 19%),這一成長歸功於對其 OviTex 增強型生物網膜產品線的需求。
對合成網片植入術後併發症的持續監測以及相關的法律糾紛,對全球疝氣修補器械市場的准入和擴張構成了重大障礙。製造商必須滿足嚴格的臨床證據標準以降低責任風險,這項要求顯著增加了研發成本並延長了核准時間。這種嚴格的法規環境迫使企業將資金用於法律辯護和合規,而非創新,延緩了下一代疝氣修補器械的商業化進程。
這些監管壓力直接降低了區域市場的吸引力和產品的可及性。根據歐洲醫療技術協會(MedTech Europe)2024年的數據,由於滿足更先進的安全性和性能要求的複雜性,選擇歐盟作為其首發市場的大型醫療設備製造商比例下降了33%。這一趨勢表明,出於安全考慮而製定的更嚴格的法規實際上限制了進入現有醫療保健系統的新產品數量。隨著先進技術的應用受到阻礙,市場正面臨收入周轉率放緩和新型修復材料在外科手術中應用率下降的雙重困境。
疝氣修補手術向門診手術中心(ASC)的轉移,從根本上改變了腹壁重組醫療服務的提供方式。保險公司和醫療系統正積極推動成本效益和提高手術周轉率,將腹股溝疝氣和腹部疝氣修復等中等急性手術從醫院住院部轉移到門診機構。大型醫療系統專科手術部門的顯著收入成長支撐了這個結構性轉變。例如,根據ASC News在2025年2月報道,Tenet Healthcare的子公司United Surgical Partners International(USPI)2024年全年淨營業收入達45億美元,較去年同期成長15.4%。這一成長主要得益於高風險病例向門診機構的轉移。
同時,生物來源和生物合成網植入的需求激增,尤其是那些採用先進聚合物技術(例如聚-4-羥基丁酸酯 (P4HB))的產品。與以往僅限於高風險患者複雜重組手術的生物來源產品不同,新型生物合成平台正進入市場,用於治療臍疝氣等常見缺陷,提供可吸收支架,在不留下永久性異物的情況下提供暫時的支撐力。這種應用得益於新一代可吸收產品組合的商業性擴張。根據 Xtalks 2025 年 4 月報道,貝克頓·迪金森公司推出了一種新型 P4HB 補片,並宣布其生物可吸收 Phasix 網片產品組合的全球植入量已超過 38.5 萬例。
The Global Hernia Repair Devices Market is projected to expand from USD 6.45 Billion in 2025 to USD 7.78 Billion by 2031, achieving a CAGR of 3.17%. These devices consist of specialized surgical meshes and fixation systems used to reconstruct or reinforce tissue walls during herniorrhaphy procedures. Growth in this sector is primarily fueled by an aging population and rising obesity rates, both of which increase physiological susceptibility to abdominal wall defects. Additionally, the continued transition toward minimally invasive laparoscopic and robotic-assisted surgeries is accelerating the demand for advanced biologic and synthetic repair materials.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 6.45 Billion |
| Market Size 2031 | USD 7.78 Billion |
| CAGR 2026-2031 | 3.17% |
| Fastest Growing Segment | Hernia Mesh Devices |
| Largest Market | North America |
However, market expansion faces headwinds due to persistent scrutiny regarding post-operative complications and litigation involving synthetic mesh implants, which can delay regulatory approvals and impact clinical adoption. Despite these regulatory challenges, procedural volumes remain high within established healthcare systems, ensuring a steady demand for repair devices. For instance, the Royal College of Surgeons of England reported that in 2024, hernia repair remained one of the most frequent surgical interventions, with more than 120,000 operations performed annually across the United Kingdom.
Market Driver
Technological progress in robotic and laparoscopic platforms is significantly reshaping the market by facilitating greater precision and faster patient recovery. This trend toward minimally invasive techniques is particularly visible in the rise of general surgery volumes, where robotic systems are increasingly becoming the standard for complex abdominal wall reconstructions. According to Intuitive Surgical's preliminary results from January 2025, worldwide da Vinci procedures increased by approximately 17% in 2024, a growth largely driven by general surgery applications in the United States. This technological adoption supports a substantial procedural workload, with TELA Bio noting in 2025 that hernia repairs remain a leading surgery in the U.S., accounting for roughly 1.5 million annual procedures.
Simultaneously, innovation in biologic and bioabsorbable mesh materials is driving market momentum as surgeons aim to reduce chronic inflammatory responses associated with permanent synthetic implants. These advanced matrices are engineered to support natural tissue remodeling and minimize the risk of recurrence, addressing a critical need for high-risk patient groups. The commercial success of these hybrid scaffolds highlights a decisive shift toward anatomy-preserving materials. As reported by Fierce Biotech in December 2025, TELA Bio announced full-year 2024 revenue of $69.3 million, representing a 19% increase attributed to the demand for its OviTex reinforced biologic mesh portfolio.
Market Challenge
The ongoing scrutiny regarding post-operative complications and legal disputes associated with synthetic mesh implants presents a significant barrier to entry and expansion in the Global Hernia Repair Devices Market. Manufacturers are compelled to meet rigorous clinical evidence standards to mitigate liability risks, a requirement that drastically inflates research and development costs while extending approval timelines. This challenging regulatory environment forces companies to divert capital toward legal defense and compliance rather than innovation, resulting in a deceleration in the commercialization of next-generation herniorrhaphy devices.
These regulatory pressures directly reduce regional market attractiveness and product availability. Data from MedTech Europe in 2024 indicates that the percentage of large medical device manufacturers choosing the European Union as their initial launch geography fell by 33 percent due to the complexities of meeting heightened safety and performance requirements. This trend illustrates how regulatory stringency, driven by safety concerns, effectively limits the volume of new products reaching established healthcare systems. By stifling the introduction of advanced technologies, the market experiences slower revenue turnover and reduced procedural adoption rates for novel repair materials.
Market Trends
The migration of hernia repair procedures to Ambulatory Surgical Centers (ASCs) is fundamentally changing the site-of-care landscape for abdominal wall reconstruction. Payors and healthcare systems are actively incentivizing the shift of intermediate-acuity surgeries, such as inguinal and ventral hernia repairs, from hospital inpatient departments to outpatient facilities to enhance cost-efficiency and procedural turnover. This structural transition is supported by substantial revenue growth in dedicated surgical divisions of major health systems. For example, ASC News reported in February 2025 that Tenet Healthcare's United Surgical Partners International (USPI) division achieved full-year 2024 net operating revenues of $4.5 billion, a 15.4% increase driven largely by the volume shift of high-acuity cases to ambulatory settings.
Concurrently, there is a surging demand for biologic and biosynthetic mesh implants, particularly those utilizing advanced polymer technologies like poly-4-hydroxybutyrate (P4HB). Unlike traditional biologics often reserved for complex reconstructions in high-risk patients, newer biosynthetic platforms are entering the market for routine defects, such as umbilical hernias, offering resorbable scaffolds that provide temporary strength without leaving permanent foreign material. This adoption is evidenced by the commercial scaling of next-generation absorbable portfolios. As noted by Xtalks in April 2025, Becton, Dickinson and Company launched a new P4HB patch and announced that its bioabsorbable Phasix Mesh portfolio has now surpassed 385,000 implants globally.
Report Scope
In this report, the Global Hernia Repair Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Hernia Repair Devices Market.
Global Hernia Repair Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: